Key points are not available for this paper at this time.
The purpose of this study is to assess the quality of brain imaging studies performed on an FDA-approved commercial 0.55T MRI system, and to provide information about the feasibility of using this scanner in a clinical workflow. The image quality of 1356 image series (378 in healthy subjects, 978 in patients) was independently rated by two neuroradiologists. While images from T1w SPACE, DWI/ADC, FLAIR, SWI, and T2w TSE sequences received acceptable image quality scores, contrast-enhanced T1w TSE sequence received lower, although acceptable, average scores. Our results suggest that neurological MRI studies for some indications can be performed at 0.55T.
Lavrova et al. (2024) studied this question.